Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Lubell
Daniel Lubell, Northridge, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080267543 | Compliant Foil Fluid Film Radial Bearing Or Seal - A compliant foil fluid film bearing or seal apparatus includes a bushing having a plurality of peripherally separate bushing segments. The bushing has a bore defined therethrough, with a peripheral portion of the bore being defined on each bushing segment. A plurality of compliant foils is carried by the bushing, with at least one of the compliant foils being disposed on each bushing segment. A plurality of foil undersprings is disposed beneath the plurality of compliant foils. | 10-30-2008 |
William Lubell, Montreal CA
| Patent application number | Description | Published |
|---|---|---|
| 20100210566 | AZAPEPTIDES AS CD36 BINDING COMPOUNDS - An azapeptide derivative of growth hormone releasing peptide (GHRP) of Formula I: A-(Xaa) | 08-19-2010 |
William A. Lubell, Montreal CA
| Patent application number | Description | Published |
|---|---|---|
| 20100038297 | Poly (Vinyl Alcohol) Polymers, Uses and Preparation Thereof - There are provided poly(vinyl alcohol) polymers and copolymers containing vinyl alcohol or vinyl acetate and derivatives thereof such as poly(ethylene glycol)-grafted poly(vinyl alcohol) polymers or polyether-grafted poly(vinyl alcohol) polymers. These polymers can contain various functional groups. Such polymers can be use as polymer matrix or solid support for various chemical substrates such as organic substrates and reagents. Cross-linked poly(vinyl alcohol) polymers and copolymers are also provided. Methods for preparing such polymers as well as several of their uses are also included. | 02-18-2010 |
William D. Lubell, Montreal CA
| Patent application number | Description | Published |
|---|---|---|
| 20100041609 | INTERLEUKIN-1 RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS OF TREATMENT - Peptides that are designed to inhibit the biological activity of the IL-1R type 1 receptor and inhibit IL-1R/IL-1RacP related cell signaling and biological activity are disclosed. Compositions comprising IL-1R antagonists of the present invention are useful in the treatment of IL-1 related diseases or conditions such as arthritis, rheumatoid arthritis, osteoarthritis, and inflammatory bowel disease as well as other chronic or acute inflammatory diseases. This invention also discloses an isolated compound having an IL-1R antagonist activity, said compound being selected from the group consisting of: a peptide comprising the amino acid sequence RYTPELX, wherein R, Y, T, P, E, L, refer to their corresponding amino acids, and X is selected from no amino acid and alanine (A); and a derivative of (a) wherein the derivative incorporates one, two or three amino acid modification selected from an amino acid addition, deletion or substitution in the RYTPEL portion of the peptide, and wherein said derivative maintains its antagonist IL-1R activity. | 02-18-2010 |
| 20100190710 | IL-23 RECEPTOR ANTAGONISTS AND USES THEREOF - The present invention relates to IL-23 receptor antagonists and agonists. The use of IL-23 receptor antagonists in treating autoimmune and inflammatory disorders, as well as methods of identifying IL-23 receptor antagonists and agonists. | 07-29-2010 |
| 20100204280 | CINNAMOYL INHIBITORS OF TRANSGLUTAMINASE - A compound of Formula, (I) or Formula: (II) | 08-12-2010 |